Evidence map›Paper›PMID 25439728›Full record

ArticleAmerican journal of human genetics2014

Mutations in SNX14 cause a distinctive autosomal-recessive cerebellar ataxia and intellectual disability syndrome.

Anna C Thomas, Hywel Williams, Núria Setó-Salvia, Chiara Bacchelli, Dagan Jenkins, Mary O'Sullivan, Konstantinos Mengrelis, Miho Ishida, Louise Ocaka, Estelle Chanudet and 24 more

Erratum issuedOpen access · hybridAbstract readCase Reports
In one paragraph

Article in American journal of human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. The evolving landscape of ER-LD contact sites.Frontiers in cell and developmental biology · 2024
    Review
  11. Article
  12. Review
  13. Compound heterozygous mutation of theFrontiers in genetics · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Macroautophagy in CNS health and disease.Nature reviews. Neuroscience · 2022
    Review
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

34 authors at 6 institutions in 4 countries.

Anna C ThomasGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Hywel WilliamsGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK; Centre for Translational Omics-GOSgene, UCL Institute of Child Health, London WC1N 1EH, UK.
Núria Setó-SalviaGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Chiara BacchelliGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK; Centre for Translational Omics-GOSgene, UCL Institute of Child Health, London WC1N 1EH, UK.
Dagan JenkinsGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Mary O'SullivanGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Konstantinos MengrelisGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Miho IshidaGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Louise OcakaGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK; Centre for Translational Omics-GOSgene, UCL Institute of Child Health, London WC1N 1EH, UK.
Estelle ChanudetGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK; Centre for Translational Omics-GOSgene, UCL Institute of Child Health, London WC1N 1EH, UK.
Chela JamesGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK; Centre for Translational Omics-GOSgene, UCL Institute of Child Health, London WC1N 1EH, UK.
Francesco LescaiGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK; Centre for Translational Omics-GOSgene, UCL Institute of Child Health, London WC1N 1EH, UK; Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Glenn AndersonHistopathology Department, Great Ormond Street Hospital, London WC1N 3JH, UK.
Deborah MorroghNE Thames Regional Genetics Laboratory Service, London WC1N 3BH, UK.
Mina RytenUCL Institute of Neurology, London WC1N 3BG, UK; Department of Clinical Genetics, Guy's Hospital, London SE1 9RT, UK.
Andrew J DuncanGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Yun Jin PaiDevelopmental Biology and Cancer, UCL Institute of Child Health, London WC1N 1EH, UK.
Jorge M SaraivaServiço de Genética Médica, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, 3000-602 Coimbra, Portugal; University Clinic of Pediatrics, Faculty of Medicine, University of Coimbra, 3000-602 Coimbra, Portugal.
Fabiana RamosServiço de Genética Médica, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, 3000-602 Coimbra, Portugal.
Bernadette FarrenClinical Genetics, Great Ormond Street Hospital, London WC1N 3JH, UK.
Dawn SaundersRadiology, Great Ormond Street Hospital, London WC1N 3JH, UK.
Bertrand VernayDevelopmental Biology and Cancer, UCL Institute of Child Health, London WC1N 1EH, UK.
Paul GissenGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Anna Straatmaan-IwanowskaGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Frank BaasDepartment of Genome Analysis, Academic Medical Center, University of Amsterdam, 1105AZ Amsterdam, the Netherlands.
Nicholas W WoodUCL Institute of Neurology, London WC1N 3BG, UK.
Joshua HershesonUCL Institute of Neurology, London WC1N 3BG, UK.
Henry HouldenUCL Institute of Neurology, London WC1N 3BG, UK.
Jane HurstClinical Genetics, Great Ormond Street Hospital, London WC1N 3JH, UK.
Richard ScottClinical Genetics, Great Ormond Street Hospital, London WC1N 3JH, UK.
Maria Bitner-GlindziczGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK; Clinical Genetics, Great Ormond Street Hospital, London WC1N 3JH, UK.
Gudrun E MooreGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK.
Sérgio B SousaGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK; Serviço de Genética Médica, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, 3000-602 Coimbra, Portugal. Electronic address: sbsousa@chc.min-saude.pt.
Philip StanierGenetics and Genomic Medicine, UCL Institute of Child Health, London WC1N 1EH, UK. Electronic address: p.stanier@ucl.ac.uk.
University College London · GBGreat Ormond Street Hospital · GBHospitais da Universidade de Coimbra · PTAarhus University · DKAcademic Medical Center · NLWessex Regional Genetics Laboratory · GB

Funding

Medical Research Council G0802462Medical Research Council G0802760Medical Research Council G1001253Medical Research Council G108/638Medical Research Council MR/J004758/1Medical Research Council MR/K01417X/1Medical Research Council MR/L009978/1Wellcome Trust 095662
6 · The paper itself

Abstract

Intellectual disability and cerebellar atrophy occur together in a large number of genetic conditions and are frequently associated with microcephaly and/or epilepsy. Here we report the identification of causal mutations in Sorting Nexin 14 (SNX14) found in seven affected individuals from three unrelated consanguineous families who presented with recessively inherited moderate-severe intellectual disability, cerebellar ataxia, early-onset cerebellar atrophy, sensorineural hearing loss, and the distinctive association of progressively coarsening facial features, relative macrocephaly, and the absence of seizures. We used homozygosity mapping and whole-exome sequencing to identify a homozygous nonsense mutation and an in-frame multiexon deletion in two families. A homozygous splice site mutation was identified by Sanger sequencing of SNX14 in a third family, selected purely by phenotypic similarity. This discovery confirms that these characteristic features represent a distinct and recognizable syndrome. SNX14 encodes a cellular protein containing Phox (PX) and regulator of G protein signaling (RGS) domains. Weighted gene coexpression network analysis predicts that SNX14 is highly coexpressed with genes involved in cellular protein metabolism and vesicle-mediated transport. All three mutations either directly affected the PX domain or diminished SNX14 levels, implicating a loss of normal cellular function. This manifested as increased cytoplasmic vacuolation as observed in cultured fibroblasts. Our findings indicate an essential role for SNX14 in neural development and function, particularly in development and maturation of the cerebellum.

Indexed as

Base SequenceCerebellar AtaxiaChromosome MappingCodon, NonsenseFemaleFibroblastsGene Regulatory NetworksGenes, RecessiveHumansIntellectual DisabilityMaleMicroscopy, ElectronMolecular Sequence DataPedigreeReverse Transcriptase Polymerase Chain ReactionSequence Analysis, DNACodon, NonsenseSNX14 protein, humanSorting Nexins

Identifiers

PMID25439728
PMCPMC4225633
OpenAlexW2105240236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.